SCHEMBL21271972

SCHEMBL21271972

COCCn1ncc2c(Br)c([N+](=O)[O-])cc(F)c21

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.36
▸ ALDH1A1 P00352 5/20 0.33
▸ PKM P14618 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ PKLR P30613 1/20 0.33
▸ CHRM1 P11229 1/20 0.32
▸ MAPK1 P28482 2/20 0.31
▸ PTGES O14684 1/20 0.31
▸ VCAM1 P19320 1/20 0.31
▸ CYP1A2 P05177 2/20 0.30
▸ CYP2D6 P10635 2/20 0.30
▸ CYP2C19 P33261 2/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CREBBP Q92793 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21272026 0.85 MAPT (0.32) MAPTALDH1A1PKMSMN1; SMN2PKLR
SCHEMBL21271993 0.80 MAPT (0.41) MAPTALDH1A1PKMSMN1; SMN2LMNA
SCHEMBL25431550 0.77 GLS (0.36) ALDH1A1LMNAVCAM1CYP1A2CYP2D6
SCHEMBL31339790 0.77 GLS (0.36) ALDH1A1LMNAVCAM1CYP1A2CYP2D6
SCHEMBL15081229 0.75 CREBBP (0.39) MAPTALDH1A1PKMLMNAPKLR
SCHEMBL14910632 0.70 TDP1 (0.41) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL30860975 0.70 TDP1 (0.41) ALDH1A1LMNACYP1A2CYP2D6CYP2C19
SCHEMBL15882234 0.69 VCAM1 (0.39) MAPTALDH1A1PKMSMN1; SMN2LMNA
SCHEMBL28667528 0.69 ALDH1A1 (0.40) MAPTALDH1A1PKMSMN1; SMN2LMNA
SCHEMBL16898946 0.68 ALDH1A1 (0.37) MAPTALDH1A1LMNAPTGESVCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492354-B2 Indazole compounds and uses thereof INCYTE CORPORATION (US) 2022-11-08 — — US disclosed
US-20210002288-A1 INDAZOLE COMPOUNDS AND USES THEREOF INCYTE CORPORATION 2021-01-07 — — US disclosed
US-20210002288-A1 INDAZOLE COMPOUNDS AND USES THEREOF INCYTE CORPORATION 2021-01-07 — — US disclosed
US-10752635-B2 Indazole compounds and uses thereof INCYTE CORPORATION (US) 2020-08-25 — — US disclosed
US-10752635-B2 Indazole compounds and uses thereof INCYTE CORPORATION (US) 2020-08-25 — — US disclosed
US-20190256520-A1 INDAZOLE COMPOUNDS AND USES THEREOF INCYTE CORPORATION 2019-08-22 — — US disclosed
US-20190256520-A1 INDAZOLE COMPOUNDS AND USES THEREOF INCYTE CORPORATION 2019-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002288-A1 INDAZOLE COMPOUNDS AND USES THEREOF PDXK, PPIP5K2, PCK1 MAPT 3880/4885ALDH1A1 2472/4885PKM 359/4885
US-10752635-B2 Indazole compounds and uses thereof PDXK, PPIP5K2, PCK1 MAPT 3880/4885ALDH1A1 2472/4885PKM 359/4885
US-20190256520-A1 INDAZOLE COMPOUNDS AND USES THEREOF PDXK, PPIP5K2, PCK1 MAPT 3880/4885ALDH1A1 2472/4885PKM 359/4885
US-11492354-B2 Indazole compounds and uses thereof PDXK, PPIP5K2, PCK1 MAPT 3880/4885ALDH1A1 2472/4885PKM 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback